Fostamatinib as a Single Agent or in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis With Severe Thrombocytopenia

Clinical trial NCT04543279 · TERMINATED

Trial details

NCT number: NCT04543279
Sponsor: Washington University School of Medicine
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelofibrosis Thrombocytopenia

Start date: 2021-05-03
Primary completion: 2022-07-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.